GEMCITABINE (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the GEMCITABINE drug offered from Fresenius Kabi USA, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | GEMCITABINE |
SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-07-26 |
END MARKETING DATE: | 0000-00-00 |
GEMCITABINE HUMAN PRESCRIPTION DRUG Details:
Item Description | GEMCITABINE from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/5.26mL) |
START MARKETING DATE: | 2011-07-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-102_bc6ffc23-0e65-471a-bb2d-2482e95437c3 |
PRODUCT NDC: | 63323-102 |
APPLICATION NUMBER: | ANDA090799 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: